On Dec. 20, 2023, the Federal Trade Commission announced its intent to file a notice of proposed rulemaking related to the Children’s Online Privacy Protection Rule — the first proposed changes to the rule in 10 years.
What are some of the key proposed changes?
…
Last week, Merck & Co. filed documents with the Supreme Court of New Jersey indicating that it reached a settlement with its “all risk” property insurers in a long-running coverage dispute involving over $1.4 billion in losses stemming from a 2017 NotPetya cyberattack that impacted tens of thousands of Merck computers. The coverage litigation, Merck & Co. v. ACE American Insurance Co., focused on the key question of whether the policies’ “hostile/warlike” exclusion applied to the NotPetya attack, which some intelligence agencies have attributed to Russian government attempts to destabilize Ukraine. The settlement was announced just a few days before the New Jersey Supreme Court was set to hear oral arguments during an appeal of the New Jersey state appeals court’s affirmance of a 2021 trial court ruling in Merck’s favor. Merck’s insurers had argued that Merck’s losses were barred by a war exclusion, but the New Jersey trial court found that the exclusion did not apply to malware and cyberattacks and instead was intended to apply only to physical acts of warfare between the armed forces of two or more countries. The terms and the amount of the settlement have not yet been disclosed.
Leavitt Equity Partners (LEP) has announced it has closed its third fund with more than $180 million.
The new fund, LEP III, surpassed the firm’s target of $150 million.
LEP, based in Salt Lake City, is a healthcare-focused PE firm. Founded in 2014, the firm manages more than $400 million in capital.
All sectors of the healthcare market are experiencing investments and growth. Dental and specialty dental practices are part of this growing trend.
In this episode of The Corner Series, McGuireWoods partner Geoff Cockrell speaks with Karan Garg, a partner and head of healthcare services at Solomon Partners, a leading financial advisory…
Last week, Merck & Co. filed documents with the Supreme Court of New Jersey indicating that it reached a settlement with its “all risk” property insurers in a long-running coverage dispute involving over $1.4 billion in losses stemming from a 2017 NotPetya cyberattack that impacted tens of thousands of Merck computers. Read on for analysis…
RoundTable Healthcare Partners has announced it has invested in EHOB.
EHOB, founded in 1985 and based in Indianapolis, specializes in the development of pressure injury prevention and patient positioning solutions.
RoundTable, based in Lake Forest, Ill., is an operating-oriented private equity firm focused exclusively on the healthcare industry. Founded in 2001, the firm…
Renovus Capital Partners has announced it has invested in Behavioral Framework.
Behavioral Framework, founded in 2017 and based in Rockville, Md., is a provider of applied behavior analysis therapy for children diagnosed with autism spectrum disorder. Behavioral Framework serves children and families across Maryland, Virginia and Washington DC.
Renovus, based in Philadelphia, is a…
Notable litigation filed during December 2023 includes: (1) Wells, et al. v. Edisto River Investors, LLC, et al.; (2) Dagan, et al. v. Greenfield, et al.; (3) SEC v. Agridime LLC, et al.; and (4) Barnett, et al. v. Bey, et al.
HCAP Partners has announced an investment in Apprio.
Apprio, founded in 1998 and based in Washington, D.C., provides healthcare technology solutions and services with a focus on automized solutions to hospitals and health systems.
HCAP Partners, based in San Diego, is a private equity firm that provides growth capital to lower middle market…
A federal appeals court recently upheld misdemeanor convictions of two former Acclarent Inc. executives for commercially distributing an adulterated and misbranded medical device by misleading the U.S. Food and Drug Administration regarding the device’s intended use.
Read on for details about the decision, which rejected claims that their off-label promotion amounted to constitutionally protected commercial…
